Bevacizumab and neutropenia Patient Reports February 10, 2012

Bevacizumab Side Effects Report #5275487-5
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Mar 22, 2007. Male patient, 71 years of age, weighting 177.0 lb, was diagnosed with tonsil cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: neutropenia, pyrexia. Bevacizumab dosage: 10 MG/KG Q 2 WEEKS IV. During the same period patient was treated with ERLOTINIB HYDROCHLORIDE, CISPLATIN. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5724017-X
Bevacizumab side effect was reported by a Physician from SPAIN on Apr 16, 2008. Male patient, weighting 114.6 lb, was diagnosed with rectal cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: dehydration, diabetic ketoacidosis, neutropenia. Bevacizumab dosage: 400 MG, Q21D. During the same period patient was treated with CAPECITABINE, OXALIPLATIN, REPAGLINIDE, METFORMINA, INSULIN. Patient died on 04/14/2008.

Bevacizumab Side Effects Report #5729521-6
Bevacizumab side effect was reported by a Physician from SPAIN on Apr 21, 2008. Male patient, weighting 114.6 lb, was diagnosed with rectal cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: dehydration, diabetic ketoacidosis, neutropenia. Bevacizumab dosage: 400 MG, Q21D. During the same period patient was treated with CAPECITABINE, OXALIPLATIN, REPAGLINIDE, METFORMINA, INSULIN. Patient died on 04/14/2008.

Bevacizumab Side Effects Report #5764174-2
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on May 26, 2008. Male patient, weighting 114.6 lb, was diagnosed with rectal cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: dehydration, diabetic ketoacidosis, neutropenia. Bevacizumab dosage: 400 MG, Q21D. During the same period patient was treated with CAPECITABINE, OXALIPLATIN, REPAGLINIDE, METFORMINA, INSULIN. Patient died on 04/14/2008.


Bevacizumab Side Effects Report #6104183-7
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Feb 18, 2009. Female patient was diagnosed with rectal cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: neutropenia, thrombophlebitis. Bevacizumab dosage: 295 MG, UNK. During the same period patient was treated with OXALIPLATIN, FLUOROURACIL, FOLINIC ACID, STILNOX, DAFALGAN, DEXERYL. Patient was hospitalized and became disabled. Patient recovered.

Bevacizumab Side Effects Report #5166002-5
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Nov 13, 2006. Male patient, 71 years of age, was diagnosed with prostate cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anaemia, aortic valve incompetence, atrial fibrillation , dilatation ventricular, haematochezia, mitral valve incompetence, neutropenia, pulmonary valve incompetence, rectal haemorrhage. Bevacizumab dosage: 15 MG/KG, Q3W, INTRAVENOUS. During the same period patient was treated with DOCETAXEL, PREDNISONE. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5888443-0
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on Sept 10, 2008. Male patient, 69 years of age, weighting 189.0 lb, was diagnosed with prostate cancer  and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: neutropenia, osteonecrosis . Bevacizumab dosage: 1390 MG, UNK. During the same period patient was treated with TAXOTERE, ACYCLOVIR, ASPIRIN, CELEXA, CLINDAMYCIN, DURAGESIC, NEURONTIN. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5927205-2
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on Oct 15, 2008. Male patient, weighting 223.8 lb, was diagnosed with prostate cancer  and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: neutropenia, pyrexia. Bevacizumab dosage: 15 MG/KG, UNK. During the same period patient was treated with TAXOTERE, LUPRON, ASPIRIN, ZOMETA, TYLENOL. Patient recovered.

Bevacizumab Side Effects Report #6121272-1
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Mar 02, 2009. Male patient was diagnosed with pleural mesothelioma malignant and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: hypertension, neutropenia, renal failure. Bevacizumab dosage: 15 MG/KG, Q3W. During the same period patient was treated with PEMETREXED, CISPLATIN, SPECIAFOLDINE. Patient was hospitalized. Patient recovered.


Bevacizumab Side Effects Report #5043213-0
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on July 03, 2006. Male patient, weighting 176.0 lb, was diagnosed with pancreatic neoplasm and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain , diarrhoea, dyspnoea, enteritis, febrile neutropenia, pyrexia, small intestinal obstruction. Bevacizumab dosage: 400 MG QS Q2WEEKS IV. During the same period patient was treated with DEXAMETHASONE, LORAZEPAM, GRANISETRON, OXALIPLATIN, LEUCOVORIN CALCIUM, FLUOROURACIL, VICODIN, IMODIUM. Patient recovered.

Bevacizumab Side Effects Report #5506413-9
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Nov 01, 2007. Female patient, weighting 125.7 lb, was diagnosed with pancreatic carcinoma metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: neutropenia. Bevacizumab dosage: 578MG Q2WKS IV. During the same period patient was treated with GEMCITABINE, DOCETAXEL. Patient recovered.

Bevacizumab Side Effects Report #5507527-X
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Nov 05, 2007. Female patient, weighting 94.80 lb, was diagnosed with pancreatic carcinoma metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: gastrointestinal haemorrhage, neutropenia. Bevacizumab dosage: 450MG Q2WKS IV. During the same period patient was treated with GEMCITABINE, DOCETAXEL. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5562787-4
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Dec 12, 2007. Female patient, weighting 94.80 lb, was diagnosed with pancreatic carcinoma metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: bile duct obstruction, disease progression, gastrointestinal haemorrhage, neutropenia, white blood cell count increased. Bevacizumab dosage: 450MG Q2WKS IV. During the same period patient was treated with GEMCITABINE, DOCETAXEL. Patient recovered.

Bevacizumab Side Effects Report #5306414-X
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Apr 11, 2007. Female patient was diagnosed with ovarian epithelial cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: neutropenia, pain , pyrexia. Bevacizumab dosage: 350 MG, UNK. During the same period patient was treated with CARBOPLATIN, PACLITAXEL. Patient was hospitalized. Patient recovered.


Bevacizumab Side Effects Report #5870961-2
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Aug 22, 2008. Female patient, weighting 152.1 lb, was diagnosed with ovarian epithelial cancer, ovarian cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: myodesopsia, neutropenia. Bevacizumab dosage: 475 MG, UNK. During the same period patient was treated with CARBOPLATIN, PACLITAXEL. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5911230-1
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Sept 23, 2008. Female patient, weighting 152.1 lb, was diagnosed with ovarian epithelial cancer, ovarian cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: myodesopsia, neutropenia. Bevacizumab dosage: 475 MG, UNK. During the same period patient was treated with CARBOPLATIN, PACLITAXEL. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5518137-2
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Nov 13, 2007. Female patient, 70 years of age, weighting 134.5 lb, was diagnosed with ovarian cancer metastatic, ovarian cancer recurrent and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anaemia, intestinal obstruction, neutropenia, thrombocytopenia. Bevacizumab dosage: 10MG/1 D KG DAYS 1, 15. During the same period patient was treated with HYCAMTIN, CALCIUM, SYNTHROID, GLUCOSAMINE, VYTORIN, ATENOLOL, COMPAZINE. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5508347-2
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Oct 25, 2007. Female patient, weighting 134.5 lb, was diagnosed with ovarian cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: intestinal obstruction, neutropenia, thrombocytopenia. Bevacizumab dosage: 590 MG, DAYS 1+15. During the same period patient was treated with TOPOTECAN, DARBEPOETIN ALFA, NEUPOGEN, CALCIUM, SYNTHROID, GLUCOSAMINE, CHONDROITIN, VYTORIN. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5615812-6
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Jan 22, 2008. Female patient was diagnosed with ovarian cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: neutropenia, pyrexia. Bevacizumab dosage: 523 MG, UNK. During the same period patient was treated with CARBOPLATIN, PACLITAXEL. Patient was hospitalized. Patient recovered.


Bevacizumab Side Effects Report #5746323-5
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on May 08, 2008. Female patient, weighting 152.1 lb, was diagnosed with ovarian cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: neutropenia, vitreous floaters. Bevacizumab dosage: 475 MG, UNK. During the same period patient was treated with CARBOPLATIN, PACLITAXEL. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5747603-X
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on May 13, 2008. Female patient was diagnosed with ovarian cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: febrile neutropenia. Bevacizumab dosage: 523 MG, UNK. During the same period patient was treated with CARBOPLATIN, PACLITAXEL. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5887075-8
Bevacizumab side effect was reported by a Physician from UNITED STATES on Sept 09, 2008. Female patient was diagnosed with ovarian cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: blood creatinine increased, haemoglobin decreased, neutropenia, renal failure acute, syncope vasovagal. Bevacizumab dosage: unknown. During the same period patient was treated with TAXOL, CISPLATIN, ACETAMINOFEN, APREPITANT, ATORVASTATIN CALCIUM, DEXAMETHASONE, DOCUSATE. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5388007-1
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on July 05, 2007. Female patient, weighting 94.98 lb, was diagnosed with oesophageal carcinoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: leukopenia, lymphopenia, neutropenia. Bevacizumab dosage: 10 MG/M2, UNK. During the same period patient was treated with DOCETAXEL, CISPLATIN, IRINOTECAN, ATENOLOL, COMPAZINE, FENTANYL TRANSDERMAL SYSTEM, MAALOX FAST BLOCKER, TYLENOL. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5466061-6
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Sept 20, 2007. Female patient, weighting 94.98 lb, was diagnosed with oesophageal carcinoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: leukopenia, lymphopenia, neutropenia. Bevacizumab dosage: 10 MG/M2, UNK. During the same period patient was treated with DOCETAXEL, CISPLATIN, IRINOTECAN, ATENOLOL, COMPAZINE, FENTANYL, MAALOX, TYLENOL. Patient was hospitalized. Patient recovered.


Bevacizumab Side Effects Report #5745905-4
Bevacizumab side effect was reported by a Pharmacist from UNITED STATES on May 13, 2008. Male patient was diagnosed with oesophageal adenocarcinoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: deep vein thrombosis , dehydration, hypocalcaemia, hypokalaemia, hypomagnesaemia, neutropenia, nodule, oesophageal ulcer, oesophagitis. Bevacizumab dosage: unknown. During the same period patient was treated with CISPLATIN, IRINOTECAN. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5252893-6
Bevacizumab side effect was reported by a Health Professional from JAPAN on Feb 11, 2007. Male patient, 60 years of age, weighting 163.1 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: c-reactive protein increased, chills, neutropenia, pyrexia, white blood cell count decreased. Bevacizumab dosage: 15 MG/KG, Q3W, INTRAVENOUS. During the same period patient was treated with CARBOPLATIN, PACLITAXEL, DICLOFENAC, REBAMIPIDE, MAGNESIUM OXIDE, NIFEDIPINE, VALSARTAN. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5531794-X
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Nov 27, 2007. Male patient, weighting 166.4 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: dyspnoea exertional, hypokalaemia, hyponatraemia, neutropenia. Bevacizumab dosage: 15 MG/KG, Q3W. During the same period patient was treated with CARBOPLATIN, GEMCITABINE, NEURONTIN, PRILOSEC, IRON SUPPLEMENT, DECADRON. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5546437-9
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Dec 04, 2007. Male patient, weighting 166.4 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: dyspnoea exertional, hypokalaemia, hyponatraemia, hypoxia, neutropenia. Bevacizumab dosage: 15 MG/KG, Q3W. During the same period patient was treated with CARBOPLATIN, GEMCITABINE, NEURONTIN, PRILOSEC, IRON SUPPLEMENT, DECADRON. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5607778-X
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Jan 24, 2008. Male patient, weighting 166.4 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: dyspnoea exertional, hypokalaemia, hyponatraemia, hypoxia, neutropenia. Bevacizumab dosage: 15 MG/KG, Q3W. During the same period patient was treated with CARBOPLATIN, GEMCITABINE, NEURONTIN, PRILOSEC, IRON SUPPLEMENT, DECADRON. Patient was hospitalized. Patient recovered.


Bevacizumab Side Effects Report #5645089-7
Bevacizumab side effect was reported by a Physician from UNITED STATES on Feb 21, 2008. Female patient was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anaemia, neutropenia. Bevacizumab dosage: 848 MG, UNK. During the same period patient was treated with ALBUTEROL, VASOTEC, POTASSIUM CHLORIDE, FOLINIC ACID, DOXYCYCLINE, BENZOYL PEROXIDE, CLINDAMYCIN LOTION, ALIMTA. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5839038-6
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Aug 01, 2008. Female patient, weighting 158.0 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: neutropenia, osteomyelitis. Bevacizumab dosage: 15 MG/KG, Q3W. During the same period patient was treated with PEMETREXED, STEROIDS. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5845835-3
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Aug 06, 2008. Female patient, weighting 158.0 lb, was diagnosed with non-small cell lung cancer, hypertension, hyperthyroidism, urinary incontinence  and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: cellulitis , neutropenia, osteomyelitis. Bevacizumab dosage: 15 MG/KG, Q3W. During the same period patient was treated with PEMETREXED, CALCIUM SUPPLEMENT, DIOVAN HCT, LEVOXYL, DETROL LA. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5875223-5
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Aug 26, 2008. Male patient was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: neutropenia, pyrexia. Bevacizumab dosage: 1100 MG, Q3W. During the same period patient was treated with DOCETAXEL, CISPLATIN, NEUPOGEN. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #6023429-7
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Dec 15, 2008. Male patient was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: neutropenia. Bevacizumab dosage: 967 MG, Q3W. During the same period patient was treated with CARBOPLATIN, PACLITAXEL, HYTRIN, GLUCOSAMINE, FINASTERIDE, SAW PALMETTO. Patient recovered.


Bevacizumab Side Effects Report #6025681-0
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Dec 19, 2008. Male patient was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: neutropenia. Bevacizumab dosage: 967 MG, Q3W. During the same period patient was treated with CARBOPLATIN, PACLITAXEL, HYTRIN, GLUCOSAMINE, FINASTERIDE, SAW PALMETTO. Patient recovered.

Bevacizumab Side Effects Report #6036341-4
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Dec 29, 2008. Male patient was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: neutropenia. Bevacizumab dosage: 967 MG, Q3W. During the same period patient was treated with CARBOPLATIN, PACLITAXEL, HYTRIN, GLUCOSAMINE, FINASTERIDE, SAW PALMETTO. Patient recovered.

Bevacizumab Side Effects Report #6053888-5
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Jan 19, 2009. Male patient, weighting 216.0 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: arthralgia, diarrhoea, dysuria, hypophagia, nausea , neutropenia, pyrexia. Bevacizumab dosage: unknown. During the same period patient was treated with CARBOPLATIN, PACLITAXEL. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5977621-8
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Dec 01, 2008. Male patient, 71 years of age, weighting 172.4 lb, was diagnosed with metastatic gastric cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anorexia, blood pressure orthostatic, dehydration, fluid intake reduced, hypophagia, nausea , neutropenia. Bevacizumab dosage: 7.5 MG/KG D1/22DAYCYCLE. During the same period patient was treated with OXALIPLATIN, DOCETAXEL, DECADRON, OMEPRAZOLE, RESTORIL, ZOFRAN. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5967955-5
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Nov 21, 2008. Female patient, 47 years of age, weighting 107.3 lb, was diagnosed with metastatic gastric cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain , catheter site related reaction, cellulitis , gastrointestinal stoma complication, nausea , neutropenia, secretion discharge. Bevacizumab dosage: 7.5 MG/KG D1/22DAYCYCLE. During the same period patient was treated with OXALIPLATIN, DOCETAXEL, COLACE, LUNESTA, OMEPRAZOLE, TRAMADOL, VITAMIN B, COMPAZINE. Patient was hospitalized. Patient recovered.


Bevacizumab Side Effects Report #5528262-8
Bevacizumab side effect was reported by a Physician from UNITED STATES on Nov 20, 2007. Male patient was diagnosed with metastatic gastric cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: intestinal obstruction, neutropenia, pyrexia. Bevacizumab dosage: 10 MG/M2, Q3W. During the same period patient was treated with DOCETAXEL, CISPLATIN, IRINOTECAN. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5588813-4
Bevacizumab side effect was reported by a Physician from UNITED STATES on Jan 02, 2008. Male patient, weighting 174.2 lb, was diagnosed with metastatic gastric cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: ileus, neutropenia, pyrexia. Bevacizumab dosage: 10 MG/M2, Q3W. During the same period patient was treated with DOCETAXEL, CISPLATIN, IRINOTECAN. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5949170-4
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Oct 28, 2008. Male patient was diagnosed with lung neoplasm and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: neutropenia, pneumonia . Bevacizumab dosage: 15.6 ML, Q3W. During the same period patient was treated with RISPERIDONE, CARBAMAZEPINE, BROMAZEPAM, ACETAMINOPHEN. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5967237-1
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Nov 13, 2008. Male patient was diagnosed with lung neoplasm and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: neutropenia, pneumonia . Bevacizumab dosage: 15.6 ML, Q3W. During the same period patient was treated with RISPERIDONE, CARBAMAZEPINE, BROMAZEPAM, PARACETAMOL. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5977998-3
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Nov 18, 2008. Male patient was diagnosed with lung neoplasm and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: neutropenia, pneumonia . Bevacizumab dosage: 15.6 ML, Q3W. During the same period patient was treated with CARBOPLATIN, GEMCITABINE, RISPERIDONE, CARBAMAZEPINE, BROMAZEPAM, ACETAMINOPHEN. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5990946-5
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Nov 27, 2008. Male patient was diagnosed with lung neoplasm and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: neutropenia, pneumonia . Bevacizumab dosage: 15.6 ML, Q3W. During the same period patient was treated with CARBOPLATIN, GEMCITABINE, RISPERIDONE, CARBAMAZEPINE, BROMAZEPAM, ACETAMINOPHEN. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #6012580-3
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Dec 04, 2008. Male patient was diagnosed with lung neoplasm and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: neutropenia, pneumonia . Bevacizumab dosage: 15.6 ML, Q3W. During the same period patient was treated with CARBOPLATIN, GEMCITABINE, RISPERIDONE, CARBAMAZEPINE, BROMAZEPAM, ACETAMINOPHEN. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #6025053-9
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Dec 18, 2008. Male patient was diagnosed with lung neoplasm and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: neutropenia, pneumonia . Bevacizumab dosage: 15.6 ML, Q3W. During the same period patient was treated with CARBOPLATIN, GEMCITABINE, RISPERIDONE, CARBAMAZEPINE, BROMAZEPAM, PARACETAMOL. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5902512-8
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Sept 15, 2008. Female patient, 53 years of age, was diagnosed with glioblastoma multiforme and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: diabetes insipidus , neutropenia, renal failure acute. Bevacizumab dosage: 10 MG/KG, Q2W. During the same period patient was treated with TEMOZOLOMIDE. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5232175-9
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Jan 22, 2007. Female patient, 59 years of age, weighting 219.8 lb, was diagnosed with glioblastoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: caecitis, cerebral haemorrhage, chest pain , dehydration, disease progression, mental status changes, neutropenia, red blood cell count decreased, thrombocytopenia. Bevacizumab dosage: 997 MG, Q2W, INTRAVENOUS. During the same period patient was treated with IRINOTECAN, CEFTAZIDIME, NEUPOGEN, DEXAMETHASONE, OXYGEN, RANITIDINE, FUROSEMIDE, OCTREOTIDE ACETATE. Patient was hospitalized and became disabled. Patient died.


Bevacizumab Side Effects Report #5144360-5
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Oct 17, 2006. Female patient, 59 years of age, weighting 219.8 lb, was diagnosed with glioblastoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: caecitis, cerebral haemorrhage, chest pain , dehydration, haematocrit decreased, mental status changes, neutropenia, red blood cell count decreased, somnolence. Bevacizumab dosage: 997 MG, Q2W, INTRAVENOUS. During the same period patient was treated with IRINOTECAN, CEFTAZIDIME, NEUPOGEN, DEXAMETHASONE, OXYGEN, RANITIDINE, FUROSEMIDE, OCTREOTIDE ACETATE. Patient was hospitalized and became disabled. Patient recovered.

Bevacizumab Side Effects Report #5155827-8
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Nov 03, 2006. Female patient, 59 years of age, weighting 219.8 lb, was diagnosed with glioblastoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: caecitis, cerebral haemorrhage, chest pain , dehydration, haematocrit decreased, mental status changes, neutropenia, red blood cell count decreased, thrombocytopenia. Bevacizumab dosage: 997 MG, Q2W, INTRAVENOUS. During the same period patient was treated with IRINOTECAN, CEFTAZIDIME, NEUPOGEN, DEXAMETHASONE, OXYGEN, RANITIDINE, FUROSEMIDE, OCTREOTIDE ACETATE. Patient was hospitalized and became disabled. Patient died.

Bevacizumab Side Effects Report #4746442-6
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Aug 16, 2005. Male patient, 24 years of age, weighting 158.7 lb, was diagnosed with gastrooesophageal cancer, metastasis and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: bacterial infection , blood culture positive, chest x-ray abnormal, neutropenia, pharyngolaryngeal pain, pyrexia, vomiting. Bevacizumab dosage: 15MG/KG IV DL EVERY 21 D. During the same period patient was treated with OXALIPLATIN, DOCETAXEL, LEXAPRO, ZITHROMAX, CARAFATE, LORTAB ELAXER. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #4752179-X
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Aug 24, 2005. Male patient, 24 years of age, weighting 158.7 lb, was diagnosed with gastrooesophageal cancer, metastasis and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: bacterial infection , blood culture positive, chest x-ray abnormal, false positive laboratory result, neutropenia, pharyngolaryngeal pain, pyrexia, sepsis , vomiting. Bevacizumab dosage: 15MG/KG IV DL EVERY 21D. During the same period patient was treated with OXALIPLATIN, DOCETAXEL, LEXAPRO, ZITHROMAX, CARAFATE, LORTAB. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #4630377-3
Bevacizumab side effect was reported by a Consumer or non-health professional from on Mar 01, 2005. Female patient, 71 years of age, was diagnosed with epithelioid sarcoma metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: leukopenia, neutropenia. Bevacizumab dosage: 15 MG/KG, Q3W, INTRAVENOUS. During the same period patient was treated with DOXORUBICIN. Patient recovered.

Bevacizumab Side Effects Report #5958540-X
Bevacizumab side effect was reported by a Health Professional from UNITED KINGDOM on Nov 04, 2008. Female patient was diagnosed with diffuse large b-cell lymphoma, non-hodgkin's lymphoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: lymphopenia, neutropenia, small intestinal obstruction, white blood cell count decreased. Bevacizumab dosage: 15 MG/KG, Q3W. During the same period patient was treated with RITUXAN, CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, PREDNISONE. Patient recovered.

Bevacizumab Side Effects Report #5958554-X
Bevacizumab side effect was reported by a Health Professional from UNITED KINGDOM on Nov 04, 2008. Female patient was diagnosed with diffuse large b-cell lymphoma, non-hodgkin's lymphoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: lymphopenia, neutropenia, small intestinal obstruction, white blood cell count decreased. Bevacizumab dosage: 15 MG/KG, Q3W. During the same period patient was treated with RITUXAN, CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, PREDNISONE. Patient recovered.

Bevacizumab Side Effects Report #4698725-6
Bevacizumab side effect was reported by a Health Professional from on June 09, 2005. Female patient, 67 years of age, weighting 164.0 lb, was diagnosed with colorectal cancer metastatic, colon cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain , haemoglobin decreased, lymphocyte count increased, neutropenia, pelvic abscess, platelet count decreased, white blood cell count decreased. Bevacizumab dosage: 5 MG/KG, Q2W, INTRAVENOUS. During the same period patient was treated with FLUOROURACIL, LEUCOVORIN CALCIUM, OXALIPLATIN, ZOCOR, PROPOLIS, VITAMIN, VITAMIN C. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #4909411-9
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Feb 10, 2006. Female patient, 56 years of age, weighting 166.0 lb, was diagnosed with colon cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: diarrhoea, malaise, neutropenia, oral intake reduced, pyrexia, vomiting. Bevacizumab dosage: 5MG/KG IV. During the same period patient was treated with OXALIPLATIN, ERLOTINIB, FLUOROURACIL, LEVOXYL, HYDROCHLOROTHIAZIDE, TOPROL, POTASSIUM CHLORIDE. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5282953-5
Bevacizumab side effect was reported by a Physician from SINGAPORE on Mar 16, 2007. Male patient, 54 years of age, was diagnosed with colon cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: bronchopulmonary aspergillosis, neutropenia. Bevacizumab dosage: unknown. During the same period patient was treated with OXALIPLATIN, FLUOROURACIL. Patient recovered.


Bevacizumab Side Effects Report #5638454-5
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Feb 11, 2008. Male patient, weighting 198.4 lb, was diagnosed with colon cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: neutropenia, pyrexia. Bevacizumab dosage: 450 MG, Q2W. During the same period patient was treated with OXALIPLATIN, LEUCOVORIN CALCIUM, FLUOROURACIL, ZESTORETIC. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5724950-9
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Apr 22, 2008. Female patient, weighting 129.0 lb, was diagnosed with colon cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: neutropenia, respiratory failure, sepsis . Bevacizumab dosage: 300 MG, Q2W. During the same period patient was treated with FLUOROURACIL, OXALIPLATIN, LEUCOVORIN CALCIUM, CIPROFLOXACIN, TENORMIN, CLONIDINE, HYZAAR. Patient was hospitalized. Patient died on 03/29/2008.

Bevacizumab Side Effects Report #5842529-5
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on July 30, 2008. Female patient, weighting 207.7 lb, was diagnosed with breast cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: dehydration, hyponatraemia, mucosal inflammation, neutropenia. Bevacizumab dosage: 15 MG/KG, Q3W. During the same period patient was treated with DOCETAXEL, CIPROFLOXACIN, TENORETIC, STILNOX. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5947513-9
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Oct 27, 2008. Female patient was diagnosed with breast cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: neutropenia, pleural effusion, pyrexia. Bevacizumab dosage: 1000 MG, Q3W. During the same period patient was treated with TAXOTERE, OMEPRAZOLE. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5977885-0
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Nov 18, 2008. Female patient was diagnosed with breast cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: neutropenia, pleural effusion, pneumonia , pyrexia. Bevacizumab dosage: 1000 MG, Q3W. During the same period patient was treated with TAXOTERE, OMEPRAZOLE. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5800837-8
Bevacizumab side effect was reported by a Physician from UNITED STATES on June 26, 2008. Female patient, 64 years of age, weighting 142.0 lb, was diagnosed with breast cancer , prophylaxis and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: neutropenia, pyrexia. Bevacizumab dosage: 10 MG/KG, Q2W. During the same period patient was treated with DOXORUBICIN, CYCLOPHOSPHAMIDE, LEVAQUIN. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5270599-4
Bevacizumab side effect was reported by a Physician from UNITED STATES on Mar 02, 2007. Female patient, 57 years of age, was diagnosed with breast cancer  and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: condition aggravated, neutropenia, sinusitis , sinusitis fungal. Bevacizumab dosage: 718 MG, Q2W, INTRAVENOUS. During the same period patient was treated with ADRIAMYCIN PFS, CYTOXAN, PACLITAXEL, NEULASTA, CETIRIZINE, MONTELUKAST. Patient recovered.

Bevacizumab Side Effects Report #5495255-9
Bevacizumab side effect was reported by a Physician from UNITED STATES on Oct 12, 2007. Female patient, 56 years of age, weighting 132.0 lb, was diagnosed with breast cancer , pyrexia, pain , nausea  and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: infection , neutropenia, pyrexia. Bevacizumab dosage: 10 MG/KG, UNK. During the same period patient was treated with ADRIAMYCIN PFS, CYTOXAN, ADVIL LIQUI, SYNTHROID, NEULASTA, ACETAMINOPHEN, LORAZEPAM. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5505682-9
Bevacizumab side effect was reported by a Physician from UNITED STATES on Oct 22, 2007. Female patient, 50 years of age, weighting 171.3 lb, was diagnosed with breast cancer  and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: hydrocephalus , ischaemic cerebral infarction, neutropenia, thrombocytopenia. Bevacizumab dosage: 15 MG/KG, UNK. During the same period patient was treated with TRASTUZUMAB, DOCETAXEL, CARBOPLATIN, ENTEX SOLUTION, FISH OIL, VITAMIN CAP, PROTONIX. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #6106495-X
Bevacizumab side effect was reported by a Physician from UNITED STATES on Feb 27, 2009. Female patient, 50 years of age, weighting 171.3 lb, was diagnosed with breast cancer  and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: haemorrhage intracranial, hydrocephalus , ischaemic cerebral infarction, neutropenia, sepsis syndrome, thrombocytopenia. Bevacizumab dosage: 15 MG/KG, UNK. During the same period patient was treated with TRASTUZUMAB, DOCETAXEL, CARBOPLATIN, ENTEX SOLUTION, FISH OIL, PROTONIX, LEVOFLOXACIN. Patient was hospitalized. Patient recovered.


Bevacizumab Side Effects Report #5405546-5
Bevacizumab side effect was reported by a Physician from UNITED STATES on July 17, 2007. Female patient was diagnosed with breast cancer  and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: aphonia, leukopenia, neutropenia, thrombocytopenia. Bevacizumab dosage: 825 MG, QD. During the same period patient was treated with IXABEPILONE. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5407871-0
Bevacizumab side effect was reported by a Physician from UNITED STATES on July 24, 2007. Female patient was diagnosed with breast cancer  and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: dysphonia, leukopenia, neutropenia, thrombocytopenia. Bevacizumab dosage: 825 MG, QD. During the same period patient was treated with IXABEPILONE. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5620549-3
Bevacizumab side effect was reported by a Physician from UNITED STATES on Feb 01, 2008. Female patient was diagnosed with breast cancer  and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: dysphonia, leukopenia, neutropenia, thrombocytopenia. Bevacizumab dosage: 825 MG, QD. During the same period patient was treated with IXABEPILONE. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5866121-1
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Aug 14, 2008. Female patient was diagnosed with breast cancer  and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: hypokalaemia, neutropenia, oesophageal candidiasis, pneumonitis. Bevacizumab dosage: 945 MG/KG, Q2W. During the same period patient was treated with ADRIAMYCIN PFS, CYTOXAN, ATIVAN, ZOFRAN, MOTRIN. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5872557-5
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Aug 21, 2008. Female patient was diagnosed with breast cancer  and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: hypokalaemia, neutropenia, oesophageal candidiasis, pneumonitis. Bevacizumab dosage: 945 MG/KG, Q2W. During the same period patient was treated with ADRIAMYCIN PFS, CYTOXAN, ATIVAN, ZOFRAN, MOTRIN. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #6054349-X
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Jan 12, 2009. Female patient was diagnosed with breast cancer  and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: cough, hypokalaemia, neutropenia, oesophageal candidiasis, pneumonitis. Bevacizumab dosage: 945 MG/KG, Q2W. During the same period patient was treated with ADRIAMYCIN PFS, ADRIAMYCIN PFS, CYTOXAN, ATIVAN, ZOFRAN, MOTRIN, TYLENOL. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #6084077-6
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Feb 04, 2009. Female patient was diagnosed with breast cancer  and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: asthma , hypokalaemia, neutropenia, oesophageal candidiasis, pneumonitis. Bevacizumab dosage: 945 MG/KG, Q2W. During the same period patient was treated with ADRIAMYCIN PFS, ADRIAMYCIN PFS, CYTOXAN, ATIVAN, ZOFRAN, MOTRIN, TYLENOL. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #6094648-9
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Feb 11, 2009. Female patient was diagnosed with breast cancer  and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: asthma , hypokalaemia, neutropenia, oesophageal candidiasis, pneumonitis. Bevacizumab dosage: 945 MG/KG, Q2W. During the same period patient was treated with ADRIAMYCIN PFS, ADRIAMYCIN PFS, CYTOXAN, ATIVAN, ZOFRAN, MOTRIN, TYLENOL. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #6113921-9
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Feb 26, 2009. Female patient was diagnosed with breast cancer  and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: leukopenia, neutropenia, pyrexia. Bevacizumab dosage: 1400 MG, Q3W. During the same period patient was treated with HERCEPTIN, TAXOTERE. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5362996-3
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on June 11, 2007. Male patient, weighting 139.3 lb, was diagnosed with bladder cancer  and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: device malfunction, neutropenia, pain , urinary tract infection . Bevacizumab dosage: 15 MG/M2, 2 DOSES. During the same period patient was treated with GEMCITABINE, CISPLATIN. Patient was hospitalized. Patient recovered.


Bevacizumab Side Effects Report #5382041-3
Bevacizumab side effect was reported by a Physician from UNITED STATES on June 28, 2007. Male patient, weighting 136.0 lb, was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: neutropenia, pyrexia. Bevacizumab dosage: 10 MG/KG, DAYS 1+15. During the same period patient was treated with IRINOTECAN, CARBOPLATIN, RISPERDAL, XALATAN, ISORDIL, PERSANTINE, TIXOCORTOL PIVALATE, TIMOPTIC. Patient was hospitalized. Patient died on 03/19/2007.